Oscotec Inc. announced that it has received KRW 29.9999073 billion in funding from Tiger Asset Management Discretionary Investment Co., Ltd., Meritz Securities Co., Ltd., Investment Arm, Asset One Asset Management

Oscotec Inc.,Ltd is a Korea-based company mainly engaged in the manufacture of functional medical materials and related products. The Company operates its business through three divisions: new medicines division, functional material products division and dental bone graft division. Its new medicines division provides osteoporosis drugs, arthritis drugs and periodontal disease drugs. Its functional material products division provides functional materials and food used for promoting bone growth and periodontal health. Its dental bone graft division provides bone graft materials, membranes and centrifuges. The Company distributes its products within domestic market and to overseas markets.